Lawrence D. Stern serves as Executive at Talecris Biotherapeutics Holdings Corp., where they oversee executive responsibilities. Since joining the company, Lawrence D. Stern has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 1, 2011 involved selling 161,850 shares valued at $0.
Lawrence D. Stern currently holds 183,292 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence D. Stern has been a net neutral trader of TLCR stock. They have purchased $0 and sold $0 worth of shares.
Lawrence D. Stern's most recent insider trade was on Jun 1, 2011, when they sold 161,850 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 1, 2011 | TLCR | $0 | Award | 33,393 | $N/A | Discretionary |
| Apr 1, 2011 | TLCR | $577.6K | Payment | 21,442 | $26.94 | Discretionary |
| Mar 31, 2011 | TLCR | $2.2M | Payment | 82,067 | $26.80 | Discretionary |
| Mar 31, 2010 | TLCR | $2.5M | Payment | 127,448 | $19.92 | Discretionary |
| Sep 30, 2009 | TLCR | $0 | Award | 45,366 | $N/A | Discretionary |